3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
238
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Recurrence
35
Burkitt Lymphoma
23
Neoplasms
20
Neoplasms, Plasma Cell
17
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Immunoglobulin Light-chain Amyloidosis
13
Leukemia
12
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma
10
Lymphoma, Large B-Cell, Diffuse
9
Lung Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Prostatic Neoplasms
8
Leukemia, Biphenotypic, Acute
8
Neoplasm Metastasis
7
Lymphoma, Non-Hodgkin
7
Breast Neoplasms
7
Lymphoma, B-Cell
6
Smoldering Multiple Myeloma
5
Nausea
5
Leukemia, Myeloid, Acute
5
Hodgkin Disease
5
Brain Neoplasms
5
Waldenstrom Macroglobulinemia
4
Neoplasm, Residual
4
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Mantle-Cell
4
Amyloidosis
4
Interventions
Cyclophosphamide
7
Etoposide
5
Prednisone
4
Doxorubicin
4
Vincristine
3
romidepsin
2
pembrolizumab
2
etoposide phosphate
2
duvelisib
2
Melphalan
2
Brentuximab Vedotin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
prednylidene
1
glofitamab
1
fludarabine phosphate
1
fludarabine
1
deltacortene
1
cemiplimab
1
brincidofovir
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Valganciclovir
1
Therapeutics
1
Tacrolimus
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Dexamethasone
×
1 year
×
Clear all
No trials found.